Baicalein inhibited the survival of MPC-1− immature myeloma cells in vitro, and induced apoptosis in myeloma cell lines by inhibiting the activity of NF-κB and thereby blocking the degradation of inhibitor-kappa B-alpha (IκB-α). Here, NFKB1 is linked to plasma cell myeloma.